Hassan M, Merza N, Nawras Y, Alfatlawi H, al obaidi hasan, Saab O, Al Zubaidi K, Al-sabbagh D, mansur S, Algodi M, Al Najafi O, Matbachi R, Al Hamdany T, Noori Z, Kobeissy A. Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation [Internet]. 2025 Jun. 30 [cited 2025 Jul. 1];13(S3). Available from: https://openjournals.utoledo.edu/index.php/translation/article/view/1397